1. S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma - short version, part 1: diagnosis, interventions for actinic keratoses, care structures and quality-of-care indicators;Heppt;J. Dtsch. Dermatol. Ges.,2020
2. S3 guideline “actinic keratosis and cutaneous squamous cell carcinoma” - update 2023, part 2: epidemiology and etiology, diagnostics, surgical and systemic treatment of cutaneous squamous cell carcinoma (cSCC), surveillance and prevention;Leiter;J. Dtsch. Dermatol. Ges.,2023
3. Phase 3 trials of tirbanibulin ointment for actinic keratosis;Blauvelt;N. Engl. J. Med.,2021
4. Preliminary evidence of efficacy, safety, and treatment satisfaction with tirbanibulin 1% ointment: a clinical perspective on actinic keratoses;Campione;Pharmaceuticals,2023
5. Line-field confocal optical coherence tomography in the treatment monitoring of actinic keratosis with tirbanibulin: a pilot study;Lacarrubba;J. Eur. Acad. Dermatol. Venereol.,2023